Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study.

Liang H, Xu Y, Chen M, Zhao J, Zhong W, Wang M

Open source

DOI
10.1186/s12967-026-08790-y
Published
2026 Aug 14
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08790-y,
  title = {Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study.},
  author = {Liang H and Xu Y and Chen M and Zhao J and Zhong W and Wang M},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-08790-y},
  url = {https://doi.org/10.1186/s12967-026-08790-y}
}

RIS

TY  - JOUR
TI  - Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study.
AU  - Liang H
AU  - Xu Y
AU  - Chen M
AU  - Zhao J
AU  - Zhong W
AU  - Wang M
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-08790-y
UR  - https://doi.org/10.1186/s12967-026-08790-y
ER  - 

APA

H, L., Y, X., M, C., J, Z., W, Z., & M, W. (2026). Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08790-y

Source records